ticlopidine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hewitt, C | 1 |
| Carton, J | 1 |
| Wakelin, S | 1 |
| Reich, A | 1 |
| Bialynicki-Birula, R | 1 |
| Szepietowski, JC | 1 |
2 other studies available for ticlopidine and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Subacute cutaneous lupus erythematosus: is clopidogrel a trigger?
Topics: Aged; Clopidogrel; Humans; Lupus Erythematosus, Cutaneous; Male; Platelet Aggregation Inhibitors; Sk | 2018 |
Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine.
Topics: Acute Disease; Aged; Female; Fibrinolytic Agents; Humans; Lupus Erythematosus, Cutaneous; Thrombosis | 2006 |